RNU6-56P

Across TCGA pan-cancer cohorts, RNU6-56P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-56P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-56P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-56P expression acts as an unfavorable survival marker.

ACC, PAAD, and KIRC are the cancer types where RNU6-56P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.066	0.667	.002	36	view →
PAAD	OS	Tertile	All	0.138	0.590	<.001	27	view →
KIRC	DFS	Tertile	All	0.320	0.651	.017	12	view →
SARC	OS	Tertile	All	0.354	0.733	.036	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-56P–ACC (DFS)

Open the ACC breakdown →